Recently, Guo Hongbo, President of Zhujiang Hospital, Southern Medical University, led a delegation of over ten clinical, research, and management experts to visit the Shenzhen-Hong Kong Cell Valley. They were warmly received by Shi Yuanyuan, Professor and Chairman of Cell Valley Group, Fu Yuchen, Director of the International Medical Service Center, Sun Rui, Head of Marketing, and Wu Hua, Project Manager. The two sides held in-depth discussions on clinical research cooperation and the transformation of scientific and technological achievements under the new "818 Policy."

Accompanied by Chairman Shi Yuanyuan, President Guo Hongbo and his delegation toured the industrial layout platform and the innovation achievement exhibition area of the Shenzhen-Hong Kong Cell Valley. They gained a preliminary understanding of Cell Valley's overall workflow and capability development in cell drug R&D, clinical translation, and industrial implementation.

During the symposium, Professor Shi Yuanyuan detailed Cell Valley's strategic layout in cell product process development, regulatory filing support, and related production and validation capabilities. He also interpreted the requirements and potential operational benefits of the "Regulations on the Administration of Clinical Research and Clinical Translation Application of Biomedical New Technologies" (referred to as "Order No. 818"). He noted that the new policy orientation will help further standardize clinical research and translation pathways, promoting the collaborative development of frontier technology research and application among industry, academia, research, and medical institutions.

President Guo Hongbo introduced the development positioning of Zhujiang Hospital as a research-oriented hospital, as well as its achievements in biomedical innovation, clinical research translation, and neurology specialty construction. He stated that cell and gene therapy is one of the strategic directions the hospital is focusing on. He emphasized that while the hospital possesses a strong foundation in clinical needs and scientific research translation scenarios, Cell Valley has extensive experience and capabilities in cell preparation, process development, and compliant production support, creating ideal conditions for in-depth cooperation.

Subsequently, both sides engaged in detailed discussions regarding specific translation project development and scientific research collaboration. In the future, both parties will jointly strive to build a new model of industry-academia-research-medicine integration driven by "clinical demand, supported by technology R&D, and guaranteed by industrial implementation." They aim to establish a close cooperation mechanism to achieve resource sharing and complementary advantages, injecting new momentum into the high-quality development of the biopharmaceutical industry in the Greater Bay Area.

About Zhujiang Hospital, Southern Medical University

Zhujiang Hospital, Southern Medical University (formerly the Second Affiliated Hospital of the First Military Medical University) was founded in 1947. In August 2004, it was transferred to Guangdong Province along with the university. It is a large comprehensive Grade A tertiary hospital integrating medical care, teaching, scientific research, and preventive healthcare. It is recognized as a high-level hospital in Guangdong Province, a demonstration hospital for public hospital reform and high-quality development, and a "flagship" hospital for integrated Chinese and Western medicine. For six consecutive years, it has received an A+ rating in the national performance assessment of tertiary public hospitals, with its comprehensive strength consistently ranking in the top tier domestically.The hospital boasts a complete disciplinary layout, with 93 specialized departments and 35 teaching and research offices. It is home to 4 national key disciplines and 26 national and provincial-level clinical key specialties. Additionally, it manages 6 regional leading hospitals, constructing a regional medical collaboration network covering eastern, western, and northern Guangdong.With a robust talent echelon, the hospital employs over 600 senior experts, 170 postdoctoral supervisors, and more than 400 doctoral and master's supervisors. A large number of experts have received national and provincial-level talent titles such as National Teaching Masters, experts receiving special government allowances from the State Council, and Young Changjiang Scholars, forming a high-quality talent team of renowned doctors, academic leaders, and young backbones.

The hospital leads the province in emergency and critical care, hosting the National Chest Pain Center and Advanced Stroke Center. It is the first Class I Trauma Center construction unit in Guangdong, a critical neonatal care center, and the Guangzhou Critical Maternal and Child Care Center. Its mature multidisciplinary collaboration model has created a top-tier domestic remote collaboration and three-dimensional transport network for the Zhujiang Specialty Medical Alliance, with its International Medical Center having served over 200,000 patients from more than 50 countries and regions.With outstanding advantages in specialty characteristics and core technologies, the hospital has formed distinct features in neurology, critical neonatology, hepatobiliary and pancreatic diseases, urogenital diseases, and integrated Chinese and Western medicine. Multiple core technologies have reached leading levels in South China and advanced levels in China. It has also been approved as a member of the first batch of the National Rare Disease Collaborative Network and other national-level diagnostic and treatment platforms.As an important clinical teaching base for Southern Medical University, the hospital possesses national-level doctoral degree authorization points and postdoctoral research stations. It undertakes multi-level medical talent training tasks and is among the first batch of national standardized residency training bases. Equipped with 20 provincial and ministerial-level research platforms and an integrated research service platform exceeding 25,000 square meters, it has won over 200 scientific research awards at various levels, including the National Science and Technology Progress Award and the National Technology Invention Award.Always adhering to the service philosophy of "People First, Hospital as Home, Care at Zhujiang," the hospital has implemented numerous smart and convenient medical measures. It has successively received honors such as the National "May 1st Labor Certificate" and the National Innovative Hospital for Improving Medical Services, striving to provide the public with safe, high-quality, and efficient medical services.